# Safety Study of XP12B in Women With Menorrhagia

> **NCT00113568** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 784 (actual)

## Conditions studied

- Menorrhagia
- Heavy Menstrual Bleeding

## Interventions

- **DRUG:** Tranexamic acid tablets (XP12B)

## Key facts

- **NCT ID:** NCT00113568
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 784 (ACTUAL)
- **Last updated:** 2010-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113568, "Safety Study of XP12B in Women With Menorrhagia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00113568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*